Kiessling, M. K., Curioni-Fontecedro, A., Samaras, P., Atrott, K., Cosin-Roger, J., Lang, S., . . . Rogler, G. (2015). Mutant HRAS as novel target for MEK and mTOR inhibitors. Oncotarget.

Kiessling, Michael K., Alessandra Curioni-Fontecedro, Panagiotis Samaras, Kirstin Atrott, Jesus Cosin-Roger, Silvia Lang, Michael Scharl, ja Gerhard Rogler. "Mutant HRAS As Novel Target for MEK and MTOR Inhibitors." Oncotarget 2015.

Kiessling, Michael K., et al. "Mutant HRAS As Novel Target for MEK and MTOR Inhibitors." Oncotarget 2015.